SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cyclo Therapeutics, Inc. – ‘8-K’ for 6/24/21 – ‘EX-3.1’

On:  Friday, 6/25/21, at 4:03pm ET   ·   For:  6/24/21   ·   Accession #:  1437749-21-15654   ·   File #:  1-39780

Previous ‘8-K’:  ‘8-K’ on / for 12/22/20   ·   Next:  ‘8-K’ on / for 8/16/21   ·   Latest:  ‘8-K/A’ on 3/4/24 for 12/27/23   ·   19 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/25/21  Cyclo Therapeutics, Inc.          8-K:5,9     6/24/21    3:634K                                   RDG Filings/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     25K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML      5K 
 3: EX-10.1     Material Contract                                   HTML    138K 


‘EX-3.1’   —   Articles of Incorporation/Organization or Bylaws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  HTML Editor  
 <>  <> 

Exhibit 3.1

 a01.jpg

 

 

a02.jpg

 

 

19 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/18/24  Cyclo Therapeutics, Inc.          10-K       12/31/23   90:11M                                    RDG Filings/FA
11/20/23  Cyclo Therapeutics, Inc.          S-4/A                  6:5.1M                                   RDG Filings/FA
11/14/23  Cyclo Therapeutics, Inc.          10-Q        9/30/23   49:3.8M                                   RDG Filings/FA
 8/14/23  Cyclo Therapeutics, Inc.          10-Q        6/30/23   47:3.8M                                   RDG Filings/FA
 5/12/23  Cyclo Therapeutics, Inc.          10-Q        3/31/23   47:3.2M                                   RDG Filings/FA
 3/17/23  Cyclo Therapeutics, Inc.          10-K       12/31/22   73:5.9M                                   RDG Filings/FA
 2/10/23  Cyclo Therapeutics, Inc.          S-1/A                  2:351K                                   RDG Filings/FA
 1/27/23  Cyclo Therapeutics, Inc.          S-1                    4:320K                                   RDG Filings/FA
11/21/22  Cyclo Therapeutics, Inc.          S-1/A                  6:905K                                   RDG Filings/FA
11/10/22  Cyclo Therapeutics, Inc.          10-Q        9/30/22   44:3.3M                                   RDG Filings/FA
10/31/22  Cyclo Therapeutics, Inc.          S-1                    3:528K                                   RDG Filings/FA
 8/15/22  Cyclo Therapeutics, Inc.          10-Q        6/30/22   44:3.2M                                   RDG Filings/FA
 5/12/22  Cyclo Therapeutics, Inc.          10-Q        3/31/22   44:2.9M                                   RDG Filings/FA
 3/11/22  Cyclo Therapeutics, Inc.          10-K       12/31/21   78:6.4M                                   RDG Filings/FA
11/18/21  Cyclo Therapeutics, Inc.          424B5                  1:264K                                   RDG Filings/FA
11/16/21  Cyclo Therapeutics, Inc.          424B5                  1:265K                                   RDG Filings/FA
11/15/21  Cyclo Therapeutics, Inc.          10-Q        9/30/21   42:3.4M                                   RDG Filings/FA
 8/16/21  Cyclo Therapeutics, Inc.          424B5                  1:242K                                   RDG Filings/FA
 8/16/21  Cyclo Therapeutics, Inc.          10-Q        6/30/21   39:2.8M                                   RDG Filings/FA
Top
Filing Submission 0001437749-21-015654   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 12:06:01.2pm ET